tm logo
QETYPRA
Live/Registered
REGISTERED

on 12 Dec 2023

Last Applicant/ Owned by

F-92100 BOULOGNE BILLANCOURT

FR

Serial Number

79337835 filed on 16th Feb 2022

Registration Number

7238318 registered on 12th Dec 2023

in the Principal Register

Correspondent Address

Ben Natter

Ben Natter Haug Partners, LLP

New York, NY 10151

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

QETYPRA

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, c Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79337835

Mark Type

No Service/Collective Mark

Attorney Docket Number

No A968-37

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Jul 2024INTERNATIONAL REGISTRATION RENEWED
29th Apr 2024FINAL DECISION TRANSACTION PROCESSED BY IB
13th Mar 2024FINAL DISPOSITION PROCESSED
13th Mar 2024FINAL DISPOSITION NOTICE SENT TO IB
12th Mar 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12th Dec 2023REGISTERED-PRINCIPAL REGISTER
12th Dec 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
31st Oct 2023NOTIFICATION PROCESSED BY IB
03rd Oct 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26th Sep 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED